Tamoxifen: from breast cancer therapy to the design of a postmenopausal prevention maintenance therapy.
Jordan
V C
VC
Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611, USA.
MacGregor
J I
JI
Tonetti
D A
DA
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D015195:Drug Design; D016889:Endometrial Neoplasms / Q000517:prevention & control*; D005260:Female; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen